Discontinuation report FOSRENOL
| Report ID | 228181 |
| Drug Identification Number | 02287161 |
| Brand name | FOSRENOL |
| Common or Proper name | Lanthanum carbonate hydrate chewable tablets |
| Company Name | TAKEDA CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | LANTHANUM |
| Strength(s) | 750MG |
| Dosage form(s) | TABLET (CHEWABLE) |
| Route of administration | ORAL ORAL |
| Packaging size | 6 Bottles of 15 tablets |
| ATC code | V03AE |
| ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2024-07-31 |
| Actual discontinuation date | |
| Remaining supply date | 2024-07-31 |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | Remaining lot expires SEP2025 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 22 ADELAIDE STREET WEST TORONTO, ONTARIO CANADA M5H 4E3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2024-05-16 | French | Compare |
| v1 | 2024-05-16 | English | Compare |
Showing 1 to 2 of 2